FDA Adverse Event Injury Summary report: N

VGXP INTLK FEMORAL LT 55

MDR report key: 7148046 · Received December 27, 2017

Report

Report Number
0001825034-2017-10910
Event Type
Injury
Date Received
December 27, 2017
Date of Event
March 18, 2016
Report Date
December 5, 2017
Manufacturer
ZIMMER BIOMET, INC.
Product Code
MBH
PMA / PMN Number
PK141407
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ZIMMER BIOMET COMPLAINT - (B)(4). CONCOMITANT PRODUCTS: CAT#195751; LOT#833150 - VANG XP INLK PRI TIB TRAY 63MM. CAT#195807; LOT#759920 - VGXP XP LAT TIB BRG LT 9X63. CAT#195877; LOT#891500 - VGXP XP MED TIB BRG LT 9X63. RELATED MFR REPORTS: 0001825034-2017-10911, 0001825034-2017-10912, 0001825034-2017-10913. REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. A REVIEW OF THE OPERATIVE RECORD INDICATES THAT THE SURGEON NOTED TIBIAL ISLAND DIDN'T STAY INTACT THROUGH FULL EXTENSION DURING TRIALING. SURGICAL NOTES WERE NOT PROVIDED; IT IS UNKNOWN WHETHER THE COMPONENTS WERE IMPLANTED WITH THE CORRECT FIT AND ORIENTATION AS PER THE SURGICAL TECHNIQUE. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. THIS REPORT IS BEING SUBMITTED LATE AS IT HAS BEEN IDENTIFIED IN REMEDIATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A LEFT KNEE SURGERY ON (B)(6) 2016. THE OPERATIVE RECORD INDICATED TIBIAL ISLAND DID NOT STAY INTACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
927042 VGXP INTLK FEMORAL LT 55 PROSTHESIS - KNEE MBH ZIMMER BIOMET, INC. N/A 498450

Patients

Seq Age Sex Outcome Treatment
1 71 YR Other